Overview

S9005 Mifepristone in Meningioma

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
To compare daily oral mifepristone vs placebo with respect to time to treatment failure in patients with unresectable meningioma.
Phase:
Phase 3
Details
Lead Sponsor:
Southwest Oncology Group
Collaborator:
National Cancer Institute (NCI)
Treatments:
Mifepristone